Elanco Animal Health Inc. (ELAN)$21.73
Currency: USD
Research Snapshot
Static fundamentals, valuation context, and investor signals for Elanco Animal Health Inc. (ELAN).
DCF ready
Valuation
49.3x
EV/FCF, 2.0% FCF yield
Quality
-2.3%
ROIC, 6.0% FCF margin
Growth
7.6%
5Y sales (revenue) CAGR
Balance sheet
0.6x
Debt/equity, 2.2x current ratio
Superinvestors
2
Top: Dodge & Cox (0.9%)
Strengths to research
- Debt/equity looks manageable at 0.6x.
- 10 annual periods are available for trend analysis.
Watchouts
- P/FCF is elevated at 38.0x.
Annual data: 10 periods
Quarterly data: 24 periods
Stock snapshot: May 25, 2026
Static dataset: May 25, 2026
Quality Scorecard
Build-time composite score for ELAN.
Grade D
32
/ 100
Financial Charts
No financial data available for ELAN (annual).
2 superinvestors own ELAN
Current quarter ownership and quarter-over-quarter share changes.
Superinvestor ownership
| Fund | Shares | Value | % Portfolio | QoQ Change |
|---|---|---|---|---|
| Dodge & Cox Dodge & Cox | 68,944,100 | $1.6B | 0.91% | 0.0% |
| Lee Ainslie Maverick Capital | 144,457 | $3M | 0.04% | 0.0% |